"I may have been swayed if this represented a major advance in the field," said panelist Walter Dunn, MD, PhD, of the ...

Otsuka Pharmaceutical Co.’s medicine for post-traumatic stress disorder with partner H. Lundbeck A/S failed to win the backing of US regulatory advisers, a major setback in the drugmakers’ bid to ...

FDA reviewers flag "discordant results" in a briefing document published ahead of Friday's advisory committee meeting for the ...

A controversial treatment offers a painless route to ridding veterans of their trauma responses. But does it really work?

Bipartisan congressional lawmakers met with the head of the U.S. Department of Veterans Affairs (VA) on Monday to discuss ...